Assignee
SICHUAN CLOVER BIOPHARMACEUTICALS INC
CN·6 granted patents·4 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
10 records- 0180US12168686B2Method of treating cancer using disulfide-linked trimeric OX40LSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2022·Granted Dec 17, 2024·0 cites·20 claims
- 0271US12280103B2Coronavirus vaccine compositions, methods, and uses thereofSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2022·Granted Apr 22, 2025·0 cites·20 claims
- 0369US11472873B2Method treating malignant ascites and metastatic pleural effusion with and disulfide-linked trimeric TRAILSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2020·Granted Oct 18, 2022·0 cites·13 claims
- 0468US11389528B2Coronavirus vaccine compositions, methods, and uses thereofSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2021·Granted Jul 19, 2022·0 cites·30 claims
- 0568US11377490B2Method for treating cancer using disulfide-linked trimeric 4-1BBLSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2020·Granted Jul 5, 2022·0 cites·17 claims
- 0661US2024391977A1Tpo mimetic fusion proteins and methods of useSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0759US12551548B2HIV vaccine compositions, methods, and uses thereofSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2021·Granted Feb 17, 2026·0 cites·20 claims
- 0853US2023218739A1Vaccine compositions, methods, and uses thereofSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0951US2023256076A1Rsv vaccine compositions, methods, and uses thereofSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1050US2023243827A1Coronavirus diagnostic compositions, methods, and uses thereofSICHUAN CLOVER BIOPHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SICHUAN CLOVER BIOPHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →